Hybridan Small Cap Feast: 28/03/2024
* A corporate client of Hybridan LLP
** Arranged by type of listing and date of announcement
*** Alphabetically arranged
**** Potential means Intention to Float (ITF) has been announced
Dish of the day
Admissions:
None
Delistings:
Asimilar Group Plc (AQSE:ASLR) has left the Aquis Stock Exchange
What’s baking in the oven? **
Potential**** Initial Public Offerings:
Helix Corporation Plc—The Company pursuing the exploration, commercial development and monetisation of a non-hydrocarbon associated helium rich gas structure in the Ingomar Dome located in central Montana, USA announces its intention to list its shares on AIM. Total capital to be raised on Admission of up to £7.5m. Expected Admission date of early April 2024.
European Green Transition **** is developing a portfolio of green economy assets in Europe which aims to capitalise on the opportunity created by the green energy transition and announces its intention to conduct a fundraise and to list its ordinary shares on AIM. The Company intends to implement a disciplined M&A focused model and has already acquired a portfolio of assets, notably their principal Olserum Rare Earth Element (REE) project.
Reverse Takeovers:
None
Change of Market:
None
Banquet Buffet***
242.5p £39.7m (BOOM.L)
The global podcast company announce the continued expansion of its creator network through new exclusive partnerships with top tier podcasts including Pretty X Unfiltered, BDA with Katherine Schwarzenegger, Soder, Omnibus, Do We Know Them?, and George Conway Explains It All To Sarah Longwell. These shows are expected to contribute more than 4 million downloads per month to the Audioboom Creator Network. Expansion of the podcast partnerships has been integral to the Company establishing the fourth biggest podcast network in the US.
0.0575p £14.7m (BOIL.L)
The oil and gas exploration and appraisal company, provides an update in relation to the offshore United Kingdom Licence P2478 (Licence), in which Baron holds a 32% interest. Offshore UK Licence P2478 will be surrendered to the UK North Sea Transition Authority (NSTA) on 31 March 2024, following unavoidable and significant delays to the acquisition of 3D seismic data, as had been stipulated in the Deed of Variation concerning the extension to Phase A of the Licence. Commitments have been fulfilled and there remain no further obligations beyond the statutory submission of a relinquishment report.
* 0.19p £5.4m (CORO.L)
The South East Asian energy company with a natural gas and clean energy portfolio, announces that binding Key Terms have been agreed for the sale and purchase of the domestic portion of Mako gas with PT Perusahaan Gas Negara Tbk (PGN), the gas subsidiary of PT Pertamina (Persero), the national oil company of Indonesia. Under these binding Key Terms, Conrad, the operator of the Duyung PSC, and PGN will agree in good faith and sign a fully termed Gas Sales Agreement (GSA) for the domestic portion of the gas produced from the Mako field located in the Duyung Production Sharing Contract (PSC). Coro has a 15% working interest in the PSC. The Company further notes updates in Mako Gas Field Resources. The net attributable to Coro 2C resources are reduced from 42.1 to 36.6 Bcf gas. Revisions pertain to the revised FID timing and delay in Mako field production startup until mid-2026.
* 0.425p £1.5m (AQSE:GCON)
The Company focused on communication services and technologies that enhance connectivity, announces that the Board has agreed that the terms of the warrants attached to shares subscribed during its IPO in October 2020, which total 101,622,400 warrants, will be amended. The Company are extending the warrant exercise period by two years from 21 April 2024 to 20 April 2026 for the 100,000,000 investor warrants and decreasing the warrant exercise price to 1.5p per share. The 1,622,400 adviser warrants which expire on 21 October 2025, will be extended by six months to 20 April 2026 and on the same terms at a warrant exercise price of 1.5p per share, which will take effect at the same time as the 100,000,000 investor warrants are being extended and amended.
275p £45.3m (JNEO.L)
The provider of information systems and technical services to transport operators and authorities, announces it has received a £1.5m purchase order from Swansea Council. The purchase order is for the manufacture, installation and maintenance of a range of the latest Journeo Thin-Film Transistor (TFT), Liquid Crystal Display (LCD) and interactive totem technologies. The revenues are included in management's expectations of performance for the current financial year and add to the Company's strong order book, providing further future revenue visibility.
* 0.0625p £1.1m (MDZ.L)
The creative audio-visual solutions provider, announces an update ahead of its Annual General Meeting (AGM) to be held at Unit 9, Woking Business Park, Albert Drive, Woking, GU21 5JY at 11:00 a.m. today. Ongoing long term project roll outs with existing customers have continued into FY24 as expected, with new projects confirmed with Pets at Home and Lululemon in the UK, a first LED installation for Arc'Teryx at its London Flagship store, and further orders secured with a large global automotive client in Europe. The Board is confident in MediaZest’s ability to deliver year-on-year growth, alongside targeting a return to profitability.
140p £162.3m (SAAS.L)
The provider of SaaS based transport technology solutions to fleet operators, announces that it has signed an initial 5-year contract for a total value of AU$20M (approximately £10.6m), with WooliesX, part of the Woolworths Group, Australia's largest supermarket chain. WooliesX has selected Microlise to deploy applications across its entire online delivery fleet operation throughout Australia. WooliesX roll out of Microlise's solutions has already begun, with the remainder taking place across the rest of 2024.
* 10p £3.9m (OHG.L)
The UK-based residential developer focused on the North of England, yesterday announced its interim results for the six months ended 31 December 2023. Revenue was £9.15m, up 59% (H1 FY23: £5.75m), as a result gross profit improved by £0.44m to a profit of £0.16m (H1 FY23: loss £0.28m). Net debt was £18.67m (H2 FY23: £16.94m) an increase of £1.73m. Post period, the Company announced Practical completion of St. Petersgate, Stockport and North Church House, Queen Street, Sheffield. The Company is on track to deliver strong revenue for FY24, driven by robust pipeline of property sales.
5.4p £6.7m (QUIZ.L)
The omni-channel fashion brand, specialising in occasion wear and dressy casual wear announces that Tarak Ramzan, Chief Executive Officer (CEO) and founder of the business, is to step down as CEO with immediate effect. Tarak, will assume a Non-Executive Director role. Sheraz Ramzan, current Chief Commercial Officer, has been appointed as Chief Executive Officer with immediate effect. The Company also provides a trading update. Sales from 1 April 2023 to 29 February 2024 amounted to £74.4m, a £10.3m or a 12% reduction on the prior year period.
* 11.25p £8.1m (SAR.L)
The biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer, announces its unaudited results for the six months ended 31 December 2023. Loss on after taxation was £2.5m and the Group held cash at 31 December 2023 of £0.4m. Post period end a UK R&D tax credit of £0.4m received in January 2024. The Company further announces a equity fundraise of up to £1.5m via the issue of new ordinary shares at 10 pence per new ordinary share, i.e. a discount of 31% to the closing price of 14.5 pence on 27 March 2024. As part of the equity raise, a retail offer is being made via Winterflood Retail Access Platform (WRAP) to raise up to £300k also at 10 pence per new share.
Status of this Note and Disclaimer
This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document is sent to you as market commentary only. As market commentary this document does not constitute any of (i) investment research and financial analysis or other forms of general recommendation relating to transactions in financial instruments for the purposes of the UK retained version of section B of annex I to Directive 2014/65/EU ("MIFID II Directive"); or (ii) investment research as defined in the UK retained version of article 36(1) of Commission Delegated Regulation 2017/565/EU made pursuant to the MIFID II Directive; or (iii) non-independent research (as such term is defined in the Financial Conduct Authority's Conduct of Business Sourcebook).
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.